Since 1983, SOFILARO Gestion, a subsidiary of the Regional Banks of Crédit Agricole Languedoc and Sud Méditerranée, has played a dynamic role in the economic landscape of the region. Our mission? Support the development of local businesses as an active, long-term minority investor, consistent with the needs and economic pace of businesses. Our commitment is manifested through four investment funds: - SOFILARO provides equity support to mature companies in their development and transfers - CALEN (Crédit Agricole Languedoc Energies Nouvelles) invests in ENR infrastructures contributing to the region's energy transition - SOFILARO PRIVATE DEBT finances business growth through private bond …

Type: Incubators & VCs

We are the international institution for public private cooperation. We connect communities of leaders around global issues through high-level meetings, research, initiatives and digital networks. We are non-profit, impartial and independent. We believe dialogue and cooperation between business, government and civil society can improve the state of the world.

Tags: H2020 Type: NGO, Think-tanks, Ed, & Culture Activities: civictech

Accelerating CNS Clinical Trials We’re developing faster, more effective tools to help our partners solve the biggest healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform. In clinical trials it provides the critical data and insights needed to accelerate the delivery of more effective CNS drugs to patients. This addresses the significant unmet need for faster, more robust and cost-effective execution and evaluation of clinical trials in neuroscience.

2 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology Data Analytics

Partner companies of your R&D The mission of AFSSI is to support and serve the development of human and animal health products. Founded in 2012, AFSSI represents service companies in preclinical R&D. With this unique sector in Europe, AFSSI responds to the global evolution of the pharmaceutical industry which entrusts the key stages of its R&D programs to expert companies like ours. The main field support for health innovation, AFSSI represents the leading R&D center in France, with 10,000 high-level jobs, 1 billion euros in turnover and 300 companies. Professional association, Sector development, Lobbying, Sector animation, Business, Service mapping, open …

Type: NGO, Think-tanks, Ed, & Culture Activities: consulting

The Voice of Global Business in Japan Established in 1948 by representatives of 40 American firms, the ACCJ, a fully independent chamber of commerce, has grown into one of the most influential business organizations in Japan, with approximately 3,000 members representing over 40 countries and 600 companies. More than 60 Chamber committees, subcommittees, task forces, and advisory councils cover such diverse areas as financial services, corporate social responsibility, marketing, independent business, healthcare services, e-business, transportation and logistics, legal services, the travel industry, and human resource management. Each committee establishes goals at the beginning of the year and meets regularly to …

Type: NGO, Think-tanks, Ed, & Culture Activities: martech

Leadership in overcoming the antibiotic resistance crisis. BioVersys AG is a SIX listed (BIOV) clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company’s two in house technology platforms: i) TRIC and ii)Ansamycin chemistry, BioVersys develops novel, innovative antibacterial drugs, overcoming resistance and modulating the microbiome. By this means, BioVersys addresses the high unmet medical need for new treatments against life-threatening resistant bacterial infections and bacteria-exacerbated chronic inflammatory microbiome disorders. Our most advanced research and development programmes address nosocomial …

39 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly digital journal, email newsletters, and social media outlets we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the health care community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes. Infectious Diseases, Publishing, Healthcare, and Communications

Type: Media

delivering therapies for inner ear disorders We are a clinical stage company delivering therapies for inner ear disorders hearing loss, pharmaceuticals, Meniere's Disease, and drug delivery

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Your Goals, Our Events: Connecting You to What Matters We are passionate about creating impactful event experiences that fuel innovation, nurture meaningful connections, and empower our communities within the life sciences and legal industries. Our research-first approach is what sets us apart: by listening to the market and engaging deeply with sector leaders, we develop content, conferences, and experiences that address the real, complex challenges faced by our audience and create momentum. We’re not just event planners—we’re facilitators of progress, conversation, and collaboration. We bring together world-class thought leaders, industry peers, and solution providers so that knowledge can be exchanged, …

48 similar entities Type: NGO, Think-tanks, Ed, & Culture Startup Activities: martech hrtech Technologies: VR

The mastermind nexus behind the corporate knowledge and intelligence of the Deep Knowledge Group. DeepTech industry analytics, benchmarking and forecasting renowned for its analytics and strategic consulting services on AI and DeepTech. Its Pharma Division is the leading provider of deep industry intelligence for the AI in Pharma sector. AI, artificial intelligence, big data, DeepTech, FinTech, data science, machine learning, GovTech, InvestTech, Blockchain, drug discovery, pharma, longevity, aging, healthspan, geroscience, agetech, preventive medicine, big data analysis, and data

103 similar entities Type: Startup Activities: it services Technologies: A.I. Data Analytics Blockchain/Cryptocurrency A.I. - Machine Learning

AI-Powered Intelligent Field Excellence for Life Sciences ACTO is an Intelligent Field Excellence (IFE) platform built for life sciences that unifies human intelligence with empathetic AI to help Sales, Medical, Market Access, and Marketing teams improve customer engagement and brand performance. With ACTO, #Biopharma companies can ensure field professionals are always competent, confident, and credible, delivering the right message to HCPs in face-to-face interactions, while providing senior leaders and frontline managers with the insight they need to drive continuous field force effectiveness. Intelligent Field Excellence, Artificial Intelligence, Sales Enablement, Sales Training, Field Force Effectiveness, Commercialization, Product Launches, Life Sciences, Biopharma, …

Type: Startup Activities: deeptech edtech it services biotech Technologies: SaaS

For over 30 years, Biocom has advanced the life science industry with transformative resources that accelerate innovation. We help companies build meaningful connections and gain valuable insights through Conferences & Events, deliver access to Funding & Partnering opportunities, provide Group Purchasing solutions that drive efficiency and savings, champion Policy & Advocacy that protects and advances the innovation ecosystem, and strengthen talent pipelines through Workforce Development. Biocom is how the life science industry gets connected. Biotech, MedicalDevice, Diagnostic, Pharmaceuticals, ServiceProvider, Marketing, Networking and PurchasingGroup., Advocacy, Membership, Public Policy, Lab Supplies, STEM, Capital Funding, Venture Capital, Investing, Life Sciences, Networking, Events, and …

Type: Incubators & VCs

A global health organization committed to saving lives, reducing the burden of disease and strengthening health systems. CHAI's mission is to save lives and improve health outcomes in low- and middle-income countries by enabling the government and private sector to strengthen and sustain quality health systems. Today, CHAI operates in 36 countries across the world and more than 80 countries have access to CHAI-negotiated price reductions, vaccines, medical devices, and diagnostics. Current programs at CHAI include HIV/AIDS, Malaria, Tuberculosis, Hepatitis, Maternal, Newborn and Reproductive Health, Diarrhea and Pneumonia, Nutrition, Vaccines, Health Financing, Health Workforce, and Cancer. CHAI also has a …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech

Increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

The ultimate resource for Healthcare & Life Sciences leaders worldwide Pharma Boardroom is the ultimate resource for Healthcare & Life Sciences leaders worldwide. We're your dedicated source for in-depth insights into both local and global markets. Our teams connect with key stakeholders in person, covering every corner of the globe. We go where others don't, conducting face-to-face meetings with industry influencers to deliver unparalleled perspectives on market dynamics. Our commitment to understanding the unique challenges and opportunities in various regions sets us apart. In an ever-evolving healthcare landscape, our extensive network allows you to access firsthand experiences from peers in …

Type: Media

Research for Tomorrow – Pioneering Drugs Against Infections. The Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) was established in 2009 as a joint venture of the Helmholtz Centre for Infection Research (HZI) and Saarland University. Located on the Saarbrücken campus, we are Germany’s first research institute dedicated explicitly to pharmaceutical research, driving innovative solutions to combat infectious diseases. Our work focuses on the development of novel anti-infectives and their optimization for clinical application – with a clear translational approach. We integrate cutting-edge strategies in synthetic and natural product-based drug discovery with advanced methods in bioinformatics and drug delivery. Our mission: …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

ProductLife Group (PLG) is a global service provider in Life Sciences, delivering end-to-end consulting and outsourcing services across the entire product lifecycle. With a presence in 150+ countries, own resources in 50+ countries, and a team of over 2,000 professionals, PLG acts as a one-stop-shop partner for the pharmaceutical, biotechnology, medical device, nutrition, and cosmetics sectors. Our mission is to support clients in accelerating innovation, ensuring compliance, and ultimately improving human health. From Product Development to Market & Patient Access, from Regulatory Affairs and Safety & Vigilance to Consulting & Digital, our global experts join forces to shape the future …

Type: SMB Activities: biotech deeptech healthtech regtech Technologies: A.I.

Knowledge beckons. Since 1456 Short profile of the University of Greifswald The University of Greifswald is one of the oldest academic educational institutions in Germany and the Baltic Sea region. Founded in 1456, it is also the oldest Swedish university, as the region was under Swedish rule until 1815 after the end of the Thirty Years' War. Today it is a tradition-conscious and modern university on the Baltic Sea with diverse international relationships and partnerships. With around 220 professorships and around 10,000 students, it is one of the medium-sized universities. The low supervision ratio and the short distances enable intensive …

Type: NGO, Think-tanks, Ed, & Culture Activities: edtech

Ending malaria, rewriting the future MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria Research and Development, Product Development Partnership (PDP), Medicines, and Malaria

37 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

The Global Health Innovative Technology Fund (GHIT Fund), headquartered in Japan, is an international public-private partnership between the Government of Japan (Ministry of Foreign Affairs and Ministry of Health, Labour and Welfare), seven Japanese pharmaceutical and diagnostics companies (Astellas, Chugai, Eisai, Daiichi Sankyo, Shionogi, Sysmex and Takeda), the Bill & Melinda Gates Foundation, Wellcome Trust, and United Nations Development Programme. GHIT funds scientific research and development for anti-infectives and diagnostics for diseases that primarily affect the developing world. GHIT is the first public-private partnership fund to involve a national government, a UN agency, a consortium of pharmaceutical and diagnostics companies, …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech deeptech

We want to stop future epidemics by developing new vaccines for a safer world. CEPI is an innovative partnership between public, private, philanthropic and civil organisations. Its mission is to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats so they can be accessible to all people in need. Central to CEPI’s pandemic-beating plan is the ‘100 Days Mission’ – its goal to develop safe, effective and accessible vaccines against new threats in just 100 days. CEPI is seeking $2.5 billion to execute CEPI 3.0, its 2027-2031 strategy, which will systematically reduce the likelihood, impact …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech

MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Accelerating your path to clinic with precision, reliability & efficiency. Reshaping drug discovery for patient benefit. Medicines Discovery Catapult (MDC): Your global accelerator for life science innovation. As a global centre of excellence, we are reshaping the landscape of drug discovery. We act as a commercially focused, strategic partner for biotech and pharma developers worldwide, providing investor-grade data and deep technical expertise to de-risk complex programs and secure clinical momentum. Bridging the gap between innovative concepts and clinical reality, we ensure the next generation of medicines reaches patients faster. Our core capability pillars: Radiopharmaceuticals, translational imaging and in vivo preclinical …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech Technologies: Synthetic Biology Data Analytics

At Maze, we envision a world where genetic insights inspire new medicines. Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. The company’s pipeline is led by two wholly owned lead …

10 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Follow us at Shionogi Inc. for news about our rare disease research programs https://www.linkedin.com/company/shionogi-inc-/ drug discovery, PDE4D, PDE4B, Fragile X, CTE, Rubinstein-Taybi, traumatic brain injury, Clinical Trials, Fragile X syndrome, Cognition, BPN14770, and Memory Loss

30 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Focusing on Resistance in Antibiotic Development Qpex Biopharma, Inc. a Shionogi Group Company, is a resistance-focused infectious disease company on a mission to make both a dramatic and sustainable improvement in patient care. Leveraging a multi-faceted approach and a deep understanding of drug resistance mechanisms, we are creating novel products and development. strategies that overcome multi-drug resistance. We are advancing a robust portfolio of treatments that will bring innovation to antibiotic development and deliver the right treatments to the right patients in the right settings. During the previous decade, our team brought 4 antibiotic products to regulatory approvals, with an …

9 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Apnimed is a clinical-stage company advancing oral medicines to treat Obstructive Sleep Apnea and related disorders. Apnimed is a clinical-stage company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders. sleep medicine and Obstructive Sleep Apnea

Type: Startup Activities: deeptech biotech

hVIVO - Making Innovation Possible Venn Life Sciences is now hVIVO. Making Innovation Possible hVIVO plc (Ticker: HVO) is a science‐led early‐phase drug development company purpose‐built to meet the growing complexity of modern clinical research. The Company operates an integrated early‐phase ecosystem that combines specialist clinical sites, advanced virology and immunology laboratories, human challenge expertise, and early drug development consulting. This unified model enables sponsors to generate rigorous, decision‐ready human data earlier in development, reducing uncertainty and accelerating progression through Phase I and II trials. With industry‐leading capabilities in respiratory and infectious disease, alongside expanding expertise in cardiometabolic and other …

46 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Reference information for the pharmaceutical sector Since 1992, economic, political and regulatory news from players in the pharmaceutical and health industries: • Organization of the health system • Legislation and regulations • Laboratory strategies • Business news and market trends • Monitoring of public and private partners • Report on major events in the sector • Biotech/medtech news • Portraits of personalities • Appointments • Cross-cutting thematic files

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Turning Research into Health The Berlin Institute of Health (BIH) is a biomedical research institution focusing on translational research and precision medicine. The BIH is dedicated to improving the prediction in progressive diseases and developing advanced therapies for unmet medical needs in order to improve patients’ health and quality of life. The Institute is committed to providing research solutions and innovation enabling value-based, personalized healthcare. The BIH is funded 90% by the Federal Ministry of Education and Research (BMBF) and 10% by the State of Berlin. The two founding institutions, Charité – Universitätsmedizin Berlin and Max Delbrück Center for Molecular …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Developing novel diagnostics compact devices to enable hospitals a better stratification of sepsis in patients. Viva’s drive is saving lives by reducing in-hospital mortality from sepsis, which is the leading cause of in-hospital deaths in the world. Our mission is to develop advanced and easy-to-use devices to solve the current problem of stratification of patients in sepsis, and in other inflammatory processes; as well as contributing to the development of novel therapies using cutting-edge scientific knowledge in the area of inflammasomes. sepsis , IVD, diagnostics, medical devices, biotech, prognosis, stratification, septic shock, acute inflammation, inflammatory diseases, inflammasomes, nlrp3, biomedical, and …

3 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

We provide advice on development strategies and events organisation to associations and learned societies Since its creation in 1953, Colloquium has been supporting numerous scientific societies and professional associations for the organization of their congresses or for the management of their associations: diabetes, ENT, orthodontics, gynecology, urology, chronic pain and radiology. In 2016 and to accompany the evolution of its client, Colloquium made a radical digital shift by restructuring 50% of its staff into web products development. 2017 will be a strategic step towards launching new products. Our services : - Digital communication agency - Professional Congress Organiser (PCO) - …

Type: Event Activities: it services

Up to date news for the Pharmaceutical and Biotechnology industries The Pharma Letter provides accurate, unbiased business information on the worldwide pharmaceutical, generic and biotechnology industries. Thousands of executives in these and allied organisations find The Pharma Letter a necessary read to keep them the first to know about current news and events, written whilst the news is fresh and has the greatest impact on commercial decisions. Save time and effort with authoritative, analysed and unbiased news delivered to you daily online straight to your screen, together with e-mail alerts and full access to The Pharma Letter's searchable archive from …

Type: Media

Leading European Law Training Since 1992 - A Trusted Partner for Legal Professionals We are the leading organisation for continuous training in European law, offering valuable opportunities to learn, discuss, and network with high-level experts and legal practitioners from diverse professional backgrounds and countries. Attending ERA events not only deepens your understanding of the constantly evolving legal framework, but also positively impacts your legal career by enhancing your skills and expanding your professional network. Established in 1992 as a non-profit foundation, the Academy of European Law serves the European public interest by providing lawyers in private practice, in-house counsel, judges, …

Type: NGO, Think-tanks, Ed, & Culture Activities: legaltech

Decoding cardiovascular disease biology for novel therapeutic discovery CardiaTec harnesses human heart multiomics data and computational modelling to develop first-in-class cardiovascular therapies. Powered by a global network of 65 hospitals, the company is developing the largest proprietary human cardiac multiomics dataset, enriched with clinical annotations to unlock novel insights into disease biology. With experts from leading organisations such as Bristol Myers Squibb, AbbVie, and Recursion, CardiaTec is redefining the discovery and development of precision cardiovascular therapies.

20 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Independent pan-European media network - a trusted source for news, analysis and debate on EU politics and policy Euractiv is an independent pan-European media network. We are an essential, trusted source for news, analysis and debate on EU politics and policy. We believe in clear, insightful, and impartial reporting, offering an independent European perspective to identify, analyse, and contextualise the impact of EU policy across Europe and beyond. Opinions, Events, Videos, Infographics, Interviews, European Policymaking, Media, Journalism, Editorial, Languages, Policy Debates, EU News, European Union, and News

Type: Media

Our research leads to new strategies in the fight against infectious diseases. At the Helmholtz Centre for Infection Research (HZI), we investigate the mechanisms of infectious diseases and develop strategies to combat them. Our interdisciplinary teams work on innovative solutions, from basic research to clinical application, aiming to sustainably improve public health. Imprint: <https://www.helmholtz-hzi.de/en/imprint> Infection research, Wirkstoffforschung, Immunology, Antibiotika, One Health, Epidemiologie, Infektionsforschung, Antibiotics, Pathogens, infectious diseases, Infections, Diagnostics, Therapies, vaccines, Anti-infectives, Pharmaceutical research, RNA-based Infection Research, Experimentelle Infektionsforschung, Klinische Infektionsforschung, and Individualised Infection Medicine

Type: Public Activities: deeptech biotech

Berlin can do health. Vivantes – with around 20,000 employees, Germany’s largest municipal hospital group and a strong healthcare network for Berlin and beyond. For 750,000 people per year, we provide excellent medical care and human touch around the clock. What makes us special? A dedicated team of Berliners and top international professionals who support each patient individually with competence and heart. Diversity, sustainability and innovation are a matter of course for us – in supply and in cooperation. We invest in good working conditions, development opportunities and real prospects, because we focus on people. Because: Working at Vivantes: Our …

Type: Large company

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For …

Type: Large company

One platform. From Insight to Action. Turn Noise into Unique, Actionable Intelligence. By unifying over 75 million structured data points from 300+ global sources, QYOBO reveals hidden patterns that your competition can't see. Built to deliver insights tailored to your company, it provides exclusive intelligence that no one else has. COMPANY As a bootstrapped company, we had no runway to waste — we had to deliver value from day one. That urgency shaped our DNA: an unwavering focus on product quality, a daily drive to make it better, and a high-performance, collaborative culture that attracts people who thrive on impact. …

2 similar entities Type: Startup Activities: transporttech Technologies: Data Analytics

Tanabe Pharma America, Inc., previously Mitsubishi Tanabe Pharma America, Inc., was launched in 2016 as a wholly-owned subsidiary of what is now Tanabe Pharma Corporation – one of the world’s oldest pharmaceutical companies. Driving scientific discovery and innovation is at the center of everything we do, and it’s more than just a passion – it’s a commitment. Tanabe Pharma America is charged with developing and advancing our pipeline as well as commercializing approved pharmaceutical products in North America. Please see our LinkedIn community guidelines here: http://www.us.tanabe-pharma.com/pdf/LinkedIn-Community-Guidelines.pdf pharmaceutical products, rare disease, innovation, research and development, and global business

13 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: IoT

The intelligence, simulation and forecasting platform for life sciences. Airfinity provides AI-powered intelligence, simulations and forecasting solutions to help life sciences organisations navigate uncertainty. Our advanced models have been built over 10 years and tested at scale. COVID-19, Oncology, and Clinical Trial Data

40 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Data Analytics A.I. - Machine Learning

The trade association giving a bigger voice to small and mid-sized innovative health technology companies in Europe For 15 years, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) has been the voice of small to mid-sized health technology companies in Europe. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through innovative therapies and medical technology. EUCOPE’s members – who represent over 2600+ innovative companies directly or via associations – are researching, designing, developing, supplying, manufacturing, and deploying the next …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech

Advancing countermeasures against 21st century health threats. Part of HHS/ASPR. https://medicalcountermeasures.gov The ​​Biomedical Advanced Research and Development Authority (BARDA), a component of the Administration for Strategic Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services, was established to aid in securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID). BARDA enhances the nation's public health security and emergency preparedness by facilitating communication on innovative products and solutions between federal agencies and public stakeholders.

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Welcome to Akili! At Akili, we believe there is potential for medicine to be developed, delivered and experienced in a completely different way. We’re bringing together world-class neuroscience with exceptional creativity and video game development to challenge the status quo of medicine. Our digital medicine is not delivered through a pill, but rather through a patented and captivating video game experience. Effective medicine that’s captivating and enjoyable to use – now that’s refreshing! We're continuously evaluating new technologies and are advancing a broad pipeline of programs to treat cognitive deficiency and improve symptoms associated with medical conditions across neurology and …

7 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming science into life-changing treatments for people living with rare diseases and drug-resistant infections. LifeArc® is a self-funded medical research organisation with one clear purpose – transforming the lives of people living with rare diseases and drug-resistant infections. We aim to deliver this by conducting and funding pioneering research, and working with partners to accelerate the translation of scientific breakthroughs into new tests and treatments. Our vision is a world where people living with rare diseases and drug-resistant infections can access effective, life-changing treatments faster. We have been doing this for more than 25 years and our work has resulted …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech biotech deeptech

Monthly peer-reviewed journal of public health. Fully open access and no author fees. Named authors alone are responsibl The Bulletin of the World Health Organization is a fully open-access journal of public health with a special focus on low and middle-income countries. It was first published in 1948 and, since then, has sought to make its full contents as widely available as possible. There are no article-processing charges associated with submitting to, or publishing in, the Bulletin. All peer-reviewed articles and the journal archives are indexed, including in the Web of Science and MEDLINE, and are freely available under the …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions. VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY’s mission is to bring innovative therapies to patients worldwide. Founded in August 2020, and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a special focus on muscle …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Collaborating in the Fight for Health The Partnership to Fight Infectious Disease (PFID) is a group of patients, providers, community organizations, business and labor groups, and health policy experts working to advance awareness and action on antimicrobial resistance. As an initiative of the Partnership to Fight Chronic Disease, PFID is focusing on the impact of this growing issue on our population and health care system. In particular, we will explore and advance solutions to address the threat of antimicrobial resistance and the need for new antimicrobial treatments.

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Established in 1992 as an export-oriented unit (EOU), Orchid Pharma Ltd is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing. We today rank among the top 50 pharmaceutical companies in India and enjoy a multi-therapeutic presence across segments like anti-infectives, Our pharmaceutical solutions include active pharmaceutical ingredients (API), We are globally present across 40+ countries through alliances and partnerships with globally reputed majors. Our integrated business model enables us to cater to business opportunities throughout the value chain, from research to delivery of drugs across therapeutic …

Type: Large company

Non-profit global partnership funding the development of products that target the most serious drug-resistant bacteria CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to supporting early-stage antibacterial research and development to address the rising threat of drug-resistant bacteria. CARB-X supports innovative therapeutics, preventatives and rapid diagnostics. CARB-X is led by Boston University and funded by a consortium of governments and foundations. CARB-X funds only projects that target the most serious, resistant bacteria identified on global priority lists, syndromes with the greatest global morbidity and mortality, and performance characteristics necessary for patients.

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech

FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. FRAXA Research Foundation is a national 501c3 nonprofit organization. FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments. Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders. FRAXA also supports families affected by Fragile X syndrome and raises …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

Our mission is to provide unwavering support for every family affected by Fragile X, while relentlessly pursuing a cure. The National Fragile X Foundation has been committed since the organization was formed in 1984 to help families, spread awareness, find improved treatments, and support research leading to better treatments and an eventual cure for all Fragile X-associated disorders. Mission The National Fragile X Foundation unites the Fragile X community to: - Enrich lives through educational and emotional support - Promote public and professional awareness - Advance research toward improved treatments and a cure for Fragile X. Advocacy, Support, Awareness, and …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech

Keeping Families Close since 1982. The Ronald McDonald House is located on the grounds of Jackson Memorial Hospital. At Ronald McDonald House, we provide essential services that remove barriers, strengthen families, and promote healing when children need healthcare. Human Services, Family, Children, Hospital services, Hospitality, Housing, Pediatric, Volunteers, Non profit, and Philanthropy

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

Connecting Corporations & Communities Through CSR Teambuilding Events! Since 2005, Impact 4 Good has been helping companies make a difference through fun and meaningful CSR-focused teambuilding events. We know it’s not always easy to find activities that benefit your cause while also engaging employees—and that’s where we come in. Our mission is to bridge that gap by creating custom philanthropic teambuilding programs that connect companies with communities. Our events promote team bonding, strengthen connections across teams, and provide valuable donations to those in need. But, we do more than just teambuilding activities. We can help you find the right nonprofit …

Type: SMB Activities: cleantech

The largest private sector coalition to provide sustainable solutions to curb antimicrobial resistance. The AMR Industry Alliance brings together over 100 research-based pharmaceutical, generics, biotech and diagnostic companies and associations, to drive and measure the life-sciences’ industry progress to curb #AMR. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measures industry’s progress in the fight against antimicrobial resistance. A first progress report was launched in January 2018, and tracked progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify …

Type: Incubators & VCs NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech

Pharmacists Advancing Healthcare ASHP is the largest association of pharmacy professionals in the United States, representing over 65,000 pharmacists, student pharmacists, and pharmacy technicians in all patient care settings, including hospitals, ambulatory clinics, and health-system community pharmacies. For over 80 years, ASHP has championed innovation in pharmacy practice, advanced education and professional development, and served as a steadfast advocate for members and patients. In addition, ASHP is an accrediting body for pharmacy residency and technician training programs and provides comprehensive resources to support pharmacy professionals through every stage of their careers. For more information, visit ashp.org and ASHP’s consumer website, …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

We are a global leadership accelerator, talent pipeline, and business growth partner for the healthcare industry. The Healthcare Businesswomen’s Association (HBA) is a global leadership accelerator, business growth partner, and enterprise solution for the healthcare and life sciences industries. With a presence in more than 80 locations worldwide, the HBA partners with nearly 150 organizations and reaches nearly six million professionals through its Corporate Partner ecosystem spanning biotech, pharmaceuticals, providers, payers, and technology. From the bench to the bedside, workforce demand for HBA membership, engagement, experiences, and market presence continues to grow across domestic and global markets. For nearly 50 …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

A global community working together to solve the challenges of infectious diseases. The Infectious Diseases Society of America is a global community of 13,000 clinicians, scientists and public health experts working together to solve humanity’s smallest and greatest challenges, from tiny microbes to global outbreaks.

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

We’re the world’s leading business voice on aging-related policy and strategy. The Global Coalition on Aging (GCOA) aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. Through research, public policy analysis, advocacy and strategic communications, GCOA is advancing innovative policy and market solutions and working to ensure global aging is a path to health, productivity, and economic growth.

Type: NGO, Think-tanks, Ed, & Culture Activities: consulting

Moving pharmaceutical companies to expand access to their products in low- & middle-income countries The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and …

49 similar entities Type: SMB Activities: healthtech civictech deeptech biotech Technologies: Synthetic Biology

Helping companies innovate and grow internationally Doing business internationally is a matter of seizing opportunities! Enterprise Europe Network (EEN) helps entrepreneurs, research institutes, universities, technology centers and business and innovation development institutions find partners worldwide free of charge. Our network consists of more than 600 organizations in more than 60 countries. In the Netherlands, the Network is implemented by the Netherlands Enterprise Agency, BOM, Business Development Friesland, Hanze University of Applied Sciences, Innovation Quarter, Horizon Flevoland, LIOF, New Energy Coalition, Water Alliance, OOST NL, ROM region Utrecht and Impuls Zeeland. What does Enterprise Europe Network offer? - Market information for …

Type: NGO, Think-tanks, Ed, & Culture Activities: it services

Influence through legitimacy Strategic consultancy in public policy. We contribute to our clients' decision making on critical policy and regulatory issues. While business success is becoming increasingly dependent on non-market management, most companies lack the methodology for them to successfully thrive in the non-market environment. A company’s ability to participate in public decision-making processes is proportional to their legitimacy. Vinces’ methodology is therefore based on the principle ‘influence through legitimacy.’ We help you build and consolidate your company’s legitimacy through our methodology in order to have a say in public decision-making, mitigate political and regulatory risks and protect your business …

Type: SMB Activities: govtech

We help international companies set up successful business operations in Western Switzerland. Greater Geneva Bern area (GGBa) is the official investment promotion agency for Western Switzerland. Its mission is to support foreign companies so that they can quickly establish and develop their operations in Western Switzerland. Its services include: providing information on business environment, taxation, operational costs and labor law; facilitating contacts with peer companies and industry groups; evaluating the best location for each company’s needs and finding suitable premises. This support is provided at no charge and on a confidential basis. Since its creation in 2010, GGBa has successfully …

Type: Public Activities: fintech

Together, we’ll make life more inclusive for deaf people and those with hearing loss or tinnitus. Together, we’ll make life more inclusive for deaf people and those with hearing loss or tinnitus.

Type: SMB Activities: healthtech

Putting public health needs at the centre of antibiotic drug development to address the crisis of AMR The Global Antibiotic Research & Development Partnership (GARDP) is a not-for-profit organization that develops new antibiotic treatments for drug-resistant bacterial infections that pose the greatest threat to human health, and makes them accessible to the people who need them. It puts public health needs at the centre of antibiotic drug development to address both the immediate antimicrobial resistance (AMR) crisis and to ensure people continue to get access to essential antibiotics for generations to come. GARDP works through a global network including Brazil, …

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech